Acne: Treatment of scars

Clinics in Dermatology

Volumn 22, Issue 5, 2004, Pages 434-438

  Jemec, Gregor B E ^a,c   Jemec, Barbara ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FLUOROURACIL; IMIQUIMOD; SILICONE;

ACNE VULGARIS; CARBON DIOXIDE LASER; CRYOTHERAPY; HUMAN; HYPERTROPHIC SCAR; KELOID; LOW LEVEL LASER THERAPY; PAIN; PRIORITY JOURNAL; PULSED DYE LASER; REVIEW; SCAR FORMATION; SKIN ABRASION; SKIN DEFECT; SKIN DISCOLORATION; SKIN GRAFT; SKIN SURGERY; SKIN ULCER; YAG LASER;

EID: 8844266144     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.03.001     Document Type: Article

References (59)

1. Stathakis V., Kilkenny M., Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 38:1997;115-123
2. Goulden V., Stables G.I., Cunliffe W.J. Prevalence of facial acne in adults. J Am Acad Dermatol. 41:1999;577-580
3. Jemec G.B.E., Lindeberg A., et al. Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris and tobacco smoking and oral contraceptives. Dermatology. 204:2002;179-184
4. Gupta M.A., Johnson A.M., Gupta A.K. The development of an acne quality of life scale reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol. 78:1998;451-456
5. Gloor M., Eicher C., Wiebelt H., et al. Sociologic studies in acne vulgaris. 1. Disease significance of acne vulgaris. Z Hautkr. 53:1978;871-880
6. Holst Larsen T., Jemec G.B.E. Acne comparing hormonal approaches to antibiotics and isotrtinoin. Exp Opin Pharmacother. 4:2003;1097-1103
7. Layton A.M., Henderson C.A., Cunliffe W.J. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 19:1994;303-308
8. Goodman G. Post-acne scarring a review. J Cosmet Laser Ther. 5:2003;77-95
9. Madden W.S., Landells I.D., Poulin Y., et al. Treatment of acne vulgaris and prevention of acne scarring Canadian consensus guidelines. J Cutan Med Surg. 4:(Suppl 1):2000;S2-13
10. Hirsch R.J., Lewis A.B. Treatment of acne scarring. Semin Cutan Med Surg. 20:2001;190-198
11. Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring a classification system and review of treatment options. J Am Acad Dermatol. 45:2001;109-117
12. Hirsch R.J., Lewis A.B. Treatment of acne scarring. Semin Cutan Med Surg. 20:2001;190-198
13. Bayat A., McGrother D.A., Ferguson M.W.J. Skin scarring. BMJ. 326:2003;88-92
14. Rogachefsky A.S., Hussain M., Goldberg D.J. Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd YAG laser. Dermatol Surg. 29:2003;904-908
15. Manuskiatti W., Fitzpatrick R.E. Treatment responses of keloidal and hypertrophic sternotomy scars comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 138:2002;1149-1155
16. Jordan R., Cummins C., Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring a systematic review of the evidence. Br J Dermatol. 142:2000;413-423
17. Baryza M.J., Baryza G.A. The Vancouver scar scale an administration tool and its interrater reliability. J Burn Care Rehabil. 16:1995;53-55
18. Bisson M.A., Grover R., Grobbelaar A.O. Long-term results of facial rejuvenation by carbon dioxide laser resurfacing using a quantitative method of assessment. Br J Plast Surg. 55:2002;652-656
19. Van den Kerckhove E., Staes F., Flour M., et al. Reproducibility of repeated measurements on post-burn scars with Dermascan C. Skin Res Technol. 9:2003;81-84
20. Grevelink J.M., White V.R. Concurrent use of laser skin resurfacing and punch excision in the treatment of facial acne scarring. Dermatol Surg. 24:1998;527-530
21. Fulton J.E. Jr, Silverton K. Resurfacing the acne-scarred face. Dermatol Surg. 25:1999;353-359
22. Jeong JT, Park JH, Kye YC. Resurfacing of pitted facial acne scars using Er:Yag laser with ablation and coagulation mode. Aesthetic Plast Surg 2003;27:130-4
23. Sawcer D., Lee H.R., Lowe N.J. Lasers and adjunctive treatment for facial scars a review. J Cutan Laser Ther. 1:1999;77-85
24. Al-Waiz M.M., Al-Sharqi A.I. Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dematol Surg. 28:2002;383-387
25. Lee J.B., Chung W.G., Kwachck H., et al. Focal treatment of acne scars with trichloroacetic acid chemical reconstruction of skin scars method. Dermatol Surg. 28:2002;1017-1021
26. Narins R.S., Brandt F., Leyden J., et al. A randomized double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 29:2003;588-595
27. DeVore D.P., Hughes E., Scott J.B. Effectiveness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med Prog Technol. 20:1994;243-250
28. Matti B.A., Nicolle F.V. Clinical use of Zyplast on correction of age- and disease-related contour deficiencies of the face. Aesthetic Plast Surg. 14:1990;227-234
29. Maas C.S., Denton A.B. Synthetic soft tissue substitutes. Facial Plast Surg Clin North Am. 9:2001;219-227. viii
30. Stegman J., Chu S., Armstrong R. Adverse reactions to bovine collagen implants clinical and histological features. J Dermatol Surg Oncol. 14:(Suppl):1998;39-48
31. Brown L.H., Frank P.J. What's new in fillers? J Drugs Dermatol. 2:2003;250-253
32. Ellis D.A., Makdessian A.S., Brown D.J. Survey of future injectables. Facial Plast Surg Clin North Am. 9:2001;405-411
33. Elson M.L. Clinical assessment of the Zyplast implant a year of experience for soft tissue contour correction. J Am Acad Dermatol. 18:1988;707-713
34. Krauss M.C. Recent advances in soft tissue augmentation. Semin Cutan Med Surg. 18:1999;119-128
35. Stegman J., Chu S., Armstrong R. Adverse reactions to bovine collagen implants clinical and histological features. J Dermatol Surg Oncol. 14:(Suppl):1998;39-48
36. Coleman S.R. Structural fat graft the ideal filler? Clin Plast Surg. 28:2001;111-119
37. International Advisory Panel on Scar Management, Mustoe T.A., Cooter R.D., Gold M.H., et al. International clinical recommendation on scar management. Plast Reconstr Surg. 110:2002;560-571
38. Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 25:1999;224-232
39. Uppal R.S., Khan U., Kakar S., et al. The effects of a single dose of 5-fluorouracil on keloid scars a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 108:2001;1218-1224
40. Gupta S., Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 204:2002;130-132
41. Bodokh I., Brun P. Treatment of keloid with intralesional bleomycin. Ann Dermatol Venereol. 123:1996;791-794
42. Espana A., Solano T., Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 27:2001;23-27
43. Sclafani A.P., Gordon L., Chadha M., et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy a randomized, prospective study and review of the literature. Dermatol Surg. 22:1996;569-574
44. Zouboulis C.C., Blume U., Buttner P., et al. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol. 129:1993;1146-1151
45. Yosipovitch G., Widijanti Sugeng M., Goon A., et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids a controlled study. J Dermatol Treat. 12:2001;87-90
46. McCraw J.B., McCraw J.A., McMellin A., et al. Prevention of unfavorable scars using early pulse dye laser treatments a preliminary report. Ann Plast Surg. 42:1999;7-14
47. Su C.W., Alizadeh K., Boddie A., et al. The problem scar. Clin Plast Surg. 25:1998;451-465
48. Philips T.J., Gerstein A.D., Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids. Dermatol Surg. 22:1996;775-778
49. Sawada Y., Sone K. Treatment of scars and keloids with a cream containing silicone oil. Br J Plast Surg. 43:1990;683-688
50. Berman B., Flores F. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars. Dermatol Surg. 25:1999;484-486
51. Gold M.H., Foster T.D., Adair M.A., et al. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 27:2001;641-644
52. Niessen F.B., Spauwen P.H., Robinson P.H., et al. The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg. 102:1998;1962-1972
53. de Oliveira G.V., Nunes T.A., Magna L.A., et al. Silicone versus non-silicone gel dressings a controlled trial. Dermatol Surg. 27:2001;721-726
54. Johnson J., Greenspan B., Gorga D., et al. Compliance with pressure garment use in burn rehabilitation. J Burn Care Rehab. 15:1994;180-188
55. Urioste S.S., Arndt K.A., Dover J.S. Keloids and hypertrophic scars review and treatment strategies. Semin Cutan Med Surg. 18:1999;159-171
56. Takeuchi M., Tredget E.E., Scott P.G., et al. The antifibrogenic effects of liposome-encapsulated IFN-alpha 2b cream on skin wounds. J Interferon Cytokine Res. 19:1999;1413-1419
57. Berman B., Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon-alpha 2b injections. J Am Acad Dermatol. 37:1997;755-757
58. al-Khawajah M.M. Failure of interferon-alpha 2b in the treatment of mature keloids. Int J Dermatol. 35:1996;515-517
59. Berman B., Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 47:(Suppl 4):2002;S209-211